Αποτελέσματα Αναζήτησης
Z01.818 is a billable/specific code for encounters prior to antineoplastic chemotherapy or other procedures. It is effective from 2023 and belongs to the category Z01.81 of nonspecific abnormal findings disclosed at examinations.
- Z01.84
Z01.84 is a billable/specific ICD-10-CM code that can be...
- Z01.84
This code is used to specify a medical diagnosis of encounter for other preprocedural examination, such as prior to chemotherapy or surgery. It is billable, exempt from POA reporting, and unacceptable as a principal diagnosis.
This code is used to specify a diagnosis of encounter for other preprocedural examination, such as before antineoplastic chemotherapy. It is a billable code that can be used to determine MS-DRG mapping and POA indicators.
1 Οκτ 2024 · Z01.818 is a valid billable code for examinations prior to antineoplastic chemotherapy or other procedures. It is found in the 2024 version of the ICD-10 Clinical Modification and belongs to category Z01 of other special examinations.
Learn the definition, guidelines, crosswalks and forum discussions for ICD-10-CM code Z01.818, which is used for encounter for other preprocedural examination. Find out when to use Z01.818 or other related codes for preoperative exams, diagnostic studies and screening tests.
3 ημέρες πριν · Z01.818 is a code for encounter for other preprocedural examination, such as a special examination without complaint or diagnosis. Find-A-Code provides access to code information, documentation, history, tips, and links for this code.
Z01.818 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM Z01.818 became effective on October 1, 2022. This is the American ICD-10-CM version of Z01.818 – other international versions of ICD-10 Z01.818 may differ.
